Jason Hulse, Co-Founder, CEO, and Chairman of PACS Group, Inc., filed a Form 4 on October 26, 2026, disclosing the sale of 82,613 shares of common stock across three transactions on October 22 and 23, 2026, under a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Reporting person: Murray Jason Hulse, Co-Founder, CEO, and Chairman of PACS Group, Inc., also identified as a Director and 10% Owner.
  • Trading plan: All sales were made pursuant to a Rule 10b5-1 trading plan adopted on May 18, 2026, according to the filing.
  • October 22 sale: 13,696 shares disposed of at a weighted average price of $47.5475, with individual transaction prices ranging from $47.50 to $47.65 per share.
  • October 23 sales: 22,722 shares sold at a weighted average of $48.2084 (range $47.50 to $48.495) and 46,195 shares sold at a weighted average of $48.7885 (range $48.50 to $49.105).
  • Remaining direct ownership: 54,188,200 shares of common stock beneficially owned directly following all reported transactions.

Details of Jason Hulse's October 2026 Share Sales at PACS Group

According to the Form 4 filed with the SEC on October 26, 2026, Murray Jason Hulse reported three separate dispositions of PACS Group, Inc. (NASDAQ:PACS) common stock. The filing indicates that all transactions were effected under a Rule 10b5-1 trading plan that Hulse adopted on May 18, 2026. The form was signed by Trevor Petersen as Attorney-in-Fact.

On October 22, 2026, the filing reports the disposal of 13,696 shares at a weighted average price of $47.5475 per share, with the underlying transactions occurring at prices between $47.50 and $47.65. On October 23, 2026, the filing reports two separate dispositions: 22,722 shares at a weighted average of $48.2084 (individual prices ranging from $47.50 to $48.495) and 46,195 shares at a weighted average of $48.7885 (individual prices ranging from $48.50 to $49.105). The filing notes that all prices in Column 4 are weighted averages, and Hulse undertakes to provide full per-transaction detail upon request by the issuer, any security holder, or SEC staff.

Following these three reported transactions, the filing states that Hulse directly beneficially owned 54,188,200 shares of PACS Group common stock. No derivative securities transactions were reported. Hulse is identified in the filing as a Director, 10% Owner, and Officer holding the title Co-Founder, CEO and Chairman.

What Was Disclosed

The filing discloses three open-market sales of PACS Group common stock by CEO Jason Hulse totaling 82,613 shares across October 22 and 23, 2026, all executed under a Rule 10b5-1 plan adopted May 18, 2026, leaving him with 54,188,200 directly held shares.